Universitetet i Oslo er et norsk forskningsintensivt statlig universitet. Det er det eldste og gjennomgående høyest rangerte universitet i Norge; frem til 1946 var det Norges eneste universitet og det beholdt sin posisjon som landets største universitet til 2016 da det ble nest størst.

During the past decade, University of Oslo conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 1 clinical trials were completed. i.e. 5.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Oslo" #1 sponsor was "University of Oslo" with 42 trials, followed by "Per Ole Iversen, MD" with 2 trials sponsored, "Cees Hertogh" with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored and "Helsinki University Central Hospital" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Oslo" #1 collaborator was "Oslo University Hospital" with 8 trials as a collaborator, "University of Oslo" with 7 trials as a collaborator, "The Research Council of Norway" with 6 trials as a collaborator, "Modum Bad" with 3 trials as a collaborator and "Oslo Metropolitan University" with 3 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "University of Oslo" are "Healthy" (7 trials), "Depression" (5 trials), "Obesity" (4 trials), "Inflammation" (3 trials) and "Overweight" (3 trials). Many other conditions were trialed in "University of Oslo" in a lesser frequency.

Most popular intervention types in "University of Oslo" are "Other" (19 trials), "Behavioral" (17 trials), "Dietary Supplement" (7 trials), "Device" (4 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Control" (2 trials), "Tuning in to Kids" (2 trials), "A structured training program" (1 trials) and "Antiatherogenic diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Oslo" are 45 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 18 active trials in "University of Oslo". 1 are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 33 completed trials in University of Oslo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Oslo, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 36 trials that are defined as “Not Applicable".